tirzepatide and estrogen The role of menopause hormone therapy in modulating tirzepatide-associated weight loss in postmenopausal women with overweight or obesity: a retrospective cohort study When my perimenopausal patients tell

Treating aged C57BL/6 mouse pancreatic islets with MOTS-c reduced pancreatic islet senescence by modulating nuclear gene expression and metabolites involved in -cell senescence

From restrictive fad diets to intentionally consuming tapeworm parasites, theres no shortage of outrageous and dangerous things people do in hopes of losing weight quickly. But, despite social and cultural pressures to be the thinnest version of yourself, obesity rates across America are the highest theyve ever been. Based on 20172020 data, the Centers for Disease Control and Prevention (CDC) report that 41.9% of American adults have obesity. Being an adult with obesity means that your Body Mass Index (BMI) also known as height to weight ratio falls outside a healthy range

This dual mechanism is what separates it from single-agonist medications like semaglutide and explains why clinical trial results showed superior weight loss outcomes

Total testosterone is the figure that shows up on a standard lab panel, and for decades it has been treated as the def

Other symptoms can include trouble sleeping, loss of appetite, and restlessness

Early clinical trials of triple agonists have shown promising results, with weight loss approaching 25% in some studies